 Nicole Tartaglia
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Klinefelter Syndrome | 15 | 2021 | 50 | 5.750 |
Why?
| | Trisomy | 19 | 2023 | 68 | 4.600 |
Why?
| | Sex Chromosome Aberrations | 19 | 2023 | 51 | 3.830 |
Why?
| | Sex Chromosomes | 18 | 2022 | 42 | 2.920 |
Why?
| | Sex Chromosome Disorders of Sex Development | 6 | 2023 | 9 | 2.780 |
Why?
| | Aneuploidy | 12 | 2022 | 85 | 2.650 |
Why?
| | Sex Chromosome Disorders | 8 | 2023 | 13 | 2.350 |
Why?
| | Autism Spectrum Disorder | 7 | 2022 | 323 | 1.990 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 9 | 2022 | 364 | 1.810 |
Why?
| | Fragile X Syndrome | 14 | 2022 | 64 | 1.740 |
Why?
| | XYY Karyotype | 10 | 2022 | 15 | 1.730 |
Why?
| | Chromosomes, Human, X | 12 | 2023 | 60 | 1.700 |
Why?
| | Prenatal Diagnosis | 7 | 2023 | 168 | 1.460 |
Why?
| | Child | 44 | 2022 | 18362 | 0.930 |
Why?
| | Developmental Disabilities | 5 | 2016 | 239 | 0.860 |
Why?
| | Phenotype | 12 | 2016 | 2817 | 0.830 |
Why?
| | Child, Preschool | 30 | 2023 | 9083 | 0.780 |
Why?
| | Cognition Disorders | 5 | 2021 | 476 | 0.730 |
Why?
| | Chromosomes, Human, Y | 3 | 2009 | 13 | 0.730 |
Why?
| | Ovarian Reserve | 1 | 2020 | 13 | 0.710 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2020 | 30 | 0.700 |
Why?
| | Adolescent | 28 | 2022 | 17826 | 0.670 |
Why?
| | Genetic Association Studies | 2 | 2021 | 345 | 0.650 |
Why?
| | Neuropsychological Tests | 12 | 2022 | 913 | 0.640 |
Why?
| | Motor Skills Disorders | 1 | 2018 | 23 | 0.630 |
Why?
| | Turner Syndrome | 1 | 2019 | 45 | 0.620 |
Why?
| | Child Behavior | 5 | 2017 | 218 | 0.610 |
Why?
| | Truth Disclosure | 2 | 2016 | 39 | 0.600 |
Why?
| | Child Development Disorders, Pervasive | 5 | 2012 | 58 | 0.600 |
Why?
| | Students | 1 | 2022 | 499 | 0.580 |
Why?
| | Genetic Testing | 4 | 2021 | 379 | 0.570 |
Why?
| | Chromosome Disorders | 2 | 2014 | 35 | 0.570 |
Why?
| | Parents | 4 | 2023 | 1191 | 0.570 |
Why?
| | Adaptation, Physiological | 1 | 2020 | 483 | 0.540 |
Why?
| | Humans | 66 | 2023 | 114925 | 0.530 |
Why?
| | Executive Function | 4 | 2022 | 376 | 0.530 |
Why?
| | Cognition | 8 | 2022 | 981 | 0.530 |
Why?
| | Karyotyping | 4 | 2020 | 103 | 0.500 |
Why?
| | Male | 46 | 2023 | 55655 | 0.500 |
Why?
| | Infant | 19 | 2023 | 7936 | 0.450 |
Why?
| | Young Adult | 14 | 2021 | 10476 | 0.440 |
Why?
| | Testosterone | 2 | 2020 | 343 | 0.430 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 904 | 0.400 |
Why?
| | Autistic Disorder | 4 | 2020 | 161 | 0.400 |
Why?
| | Parent-Child Relations | 1 | 2014 | 234 | 0.400 |
Why?
| | Language Development Disorders | 3 | 2019 | 38 | 0.390 |
Why?
| | Adolescent Development | 1 | 2012 | 83 | 0.380 |
Why?
| | Female | 29 | 2023 | 59571 | 0.380 |
Why?
| | Abnormalities, Multiple | 3 | 2012 | 177 | 0.360 |
Why?
| | Obesity | 2 | 2020 | 2514 | 0.360 |
Why?
| | Tremor | 2 | 2009 | 45 | 0.350 |
Why?
| | Hormone Replacement Therapy | 1 | 2010 | 77 | 0.350 |
Why?
| | Emotions | 4 | 2023 | 472 | 0.340 |
Why?
| | Adult | 21 | 2023 | 30604 | 0.320 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 1729 | 0.320 |
Why?
| | Attention | 5 | 2022 | 392 | 0.320 |
Why?
| | Child Development | 1 | 2012 | 387 | 0.300 |
Why?
| | Adolescent Behavior | 2 | 2012 | 488 | 0.300 |
Why?
| | Pregnancy | 4 | 2023 | 5525 | 0.270 |
Why?
| | Genetic Counseling | 3 | 2023 | 65 | 0.270 |
Why?
| | Fragile X Mental Retardation Protein | 5 | 2022 | 51 | 0.270 |
Why?
| | Case-Control Studies | 4 | 2020 | 3008 | 0.260 |
Why?
| | Perceptual Disorders | 2 | 2019 | 20 | 0.250 |
Why?
| | DiGeorge Syndrome | 2 | 2019 | 18 | 0.250 |
Why?
| | Space Perception | 2 | 2019 | 63 | 0.240 |
Why?
| | Comorbidity | 5 | 2022 | 1458 | 0.230 |
Why?
| | Child Behavior Disorders | 3 | 2016 | 131 | 0.230 |
Why?
| | Y Chromosome | 1 | 2023 | 6 | 0.230 |
Why?
| | Visual Perception | 2 | 2019 | 139 | 0.230 |
Why?
| | Behavior | 2 | 2019 | 92 | 0.220 |
Why?
| | Cell Adhesion Molecules, Neuronal | 2 | 2015 | 35 | 0.220 |
Why?
| | Seizures | 4 | 2022 | 340 | 0.220 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2001 | 106 | 0.220 |
Why?
| | Syndrome | 4 | 2020 | 336 | 0.220 |
Why?
| | Behavioral Symptoms | 2 | 2022 | 40 | 0.220 |
Why?
| | Mitral Valve Prolapse | 1 | 2022 | 8 | 0.210 |
Why?
| | Puberty | 2 | 2016 | 135 | 0.210 |
Why?
| | Social Behavior | 3 | 2022 | 267 | 0.200 |
Why?
| | Social Change | 1 | 2022 | 13 | 0.200 |
Why?
| | Mental Disorders | 2 | 2017 | 891 | 0.200 |
Why?
| | Theory of Mind | 1 | 2022 | 9 | 0.200 |
Why?
| | Cross-Sectional Studies | 6 | 2022 | 4406 | 0.200 |
Why?
| | Calcium-Binding Proteins | 2 | 2012 | 207 | 0.200 |
Why?
| | Cannabidiol | 1 | 2022 | 60 | 0.190 |
Why?
| | Surveys and Questionnaires | 5 | 2022 | 4634 | 0.190 |
Why?
| | Food, Formulated | 1 | 2020 | 14 | 0.180 |
Why?
| | Cyclic AMP | 1 | 2001 | 225 | 0.180 |
Why?
| | Gonadotropins | 1 | 2020 | 37 | 0.180 |
Why?
| | Educational Status | 1 | 2022 | 409 | 0.180 |
Why?
| | Glutamates | 1 | 2020 | 58 | 0.170 |
Why?
| | Toilet Training | 1 | 2019 | 2 | 0.170 |
Why?
| | Anti-Mullerian Hormone | 1 | 2020 | 50 | 0.170 |
Why?
| | Waist Circumference | 1 | 2020 | 122 | 0.170 |
Why?
| | Infant Formula | 1 | 2020 | 74 | 0.170 |
Why?
| | Time Perception | 1 | 2019 | 24 | 0.170 |
Why?
| | Mathematical Concepts | 1 | 2019 | 24 | 0.170 |
Why?
| | Hippocampus | 2 | 2001 | 696 | 0.170 |
Why?
| | Counseling | 1 | 2022 | 342 | 0.170 |
Why?
| | Intelligence | 1 | 2020 | 131 | 0.170 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 66 | 0.160 |
Why?
| | Irritable Mood | 1 | 2019 | 47 | 0.160 |
Why?
| | Problem Behavior | 1 | 2020 | 86 | 0.160 |
Why?
| | Synapses | 2 | 2001 | 330 | 0.160 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 133 | 0.160 |
Why?
| | Auditory Perception | 1 | 2019 | 102 | 0.160 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 183 | 0.160 |
Why?
| | Face | 1 | 2020 | 168 | 0.160 |
Why?
| | Neurodevelopmental Disorders | 1 | 2020 | 109 | 0.160 |
Why?
| | Self-Injurious Behavior | 1 | 2019 | 114 | 0.150 |
Why?
| | Triglycerides | 1 | 2020 | 470 | 0.150 |
Why?
| | Mosaicism | 2 | 2016 | 61 | 0.150 |
Why?
| | Memory, Short-Term | 1 | 2020 | 223 | 0.150 |
Why?
| | Aggression | 1 | 2019 | 184 | 0.150 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 184 | 0.150 |
Why?
| | Prader-Willi Syndrome | 1 | 2017 | 25 | 0.150 |
Why?
| | Eosinophilic Esophagitis | 1 | 2021 | 296 | 0.140 |
Why?
| | Oxandrolone | 1 | 2017 | 8 | 0.140 |
Why?
| | Estradiol | 1 | 2020 | 455 | 0.140 |
Why?
| | Cohort Studies | 3 | 2020 | 4903 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 256 | 0.140 |
Why?
| | Disability Evaluation | 1 | 2018 | 271 | 0.140 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 323 | 0.140 |
Why?
| | Facies | 1 | 2016 | 21 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 517 | 0.140 |
Why?
| | Down Syndrome | 2 | 2013 | 338 | 0.140 |
Why?
| | X Chromosome Inactivation | 1 | 2016 | 21 | 0.140 |
Why?
| | Speech Disorders | 1 | 2016 | 30 | 0.140 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2542 | 0.130 |
Why?
| | Transcription Factors | 1 | 2023 | 1530 | 0.130 |
Why?
| | Testis | 1 | 2016 | 133 | 0.130 |
Why?
| | Registries | 2 | 2020 | 1760 | 0.130 |
Why?
| | Androgens | 1 | 2017 | 167 | 0.130 |
Why?
| | Physical Examination | 1 | 2016 | 220 | 0.120 |
Why?
| | Nerve Tissue Proteins | 3 | 2012 | 529 | 0.120 |
Why?
| | Neuroimaging | 1 | 2016 | 248 | 0.120 |
Why?
| | Muscle Strength | 1 | 2017 | 270 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2102 | 0.110 |
Why?
| | Polymorphism, Genetic | 1 | 2016 | 612 | 0.110 |
Why?
| | Trisomy 13 Syndrome | 1 | 2013 | 3 | 0.110 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2013 | 16 | 0.110 |
Why?
| | Body Mass Index | 1 | 2020 | 1961 | 0.110 |
Why?
| | Self Concept | 1 | 2014 | 214 | 0.110 |
Why?
| | Tetrasomy | 1 | 2012 | 3 | 0.100 |
Why?
| | Wechsler Scales | 1 | 2012 | 52 | 0.100 |
Why?
| | Exons | 1 | 2012 | 302 | 0.090 |
Why?
| | Trinucleotide Repeat Expansion | 2 | 2008 | 24 | 0.090 |
Why?
| | Intellectual Disability | 1 | 2012 | 130 | 0.090 |
Why?
| | Hypogonadism | 1 | 2011 | 75 | 0.090 |
Why?
| | Gene Deletion | 1 | 2012 | 356 | 0.090 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2012 | 483 | 0.090 |
Why?
| | Data Collection | 1 | 2013 | 623 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1523 | 0.090 |
Why?
| | Nonlinear Dynamics | 1 | 2010 | 83 | 0.080 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2008 | 121 | 0.080 |
Why?
| | Body Height | 1 | 2010 | 180 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 6218 | 0.080 |
Why?
| | Language Disorders | 1 | 2009 | 32 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1182 | 0.080 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2008 | 39 | 0.070 |
Why?
| | Middle Aged | 6 | 2019 | 26801 | 0.070 |
Why?
| | Chromosome Deletion | 1 | 2008 | 96 | 0.070 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2008 | 69 | 0.070 |
Why?
| | Genotype | 1 | 2012 | 1775 | 0.070 |
Why?
| | Psychomotor Performance | 1 | 2009 | 280 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 8637 | 0.070 |
Why?
| | United States | 1 | 2022 | 12209 | 0.070 |
Why?
| | Vagus Nerve | 2 | 1997 | 81 | 0.060 |
Why?
| | Prevalence | 2 | 2021 | 2251 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2020 | 1663 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2096 | 0.060 |
Why?
| | Time Factors | 2 | 2013 | 6125 | 0.050 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2003 | 53 | 0.050 |
Why?
| | Gene Duplication | 1 | 2003 | 63 | 0.050 |
Why?
| | Interleukin-1 | 3 | 1997 | 966 | 0.050 |
Why?
| | Muscle Hypotonia | 2 | 2013 | 31 | 0.050 |
Why?
| | Gels | 1 | 2022 | 72 | 0.050 |
Why?
| | Anxiety | 2 | 2020 | 846 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2013 | 5035 | 0.050 |
Why?
| | Mental Status and Dementia Tests | 1 | 2022 | 21 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 3 | 2010 | 314 | 0.050 |
Why?
| | Abnormal Karyotype | 1 | 2021 | 3 | 0.050 |
Why?
| | Synaptotagmins | 1 | 2001 | 20 | 0.050 |
Why?
| | Vocabulary | 1 | 2021 | 40 | 0.050 |
Why?
| | Synaptic Vesicles | 1 | 2001 | 37 | 0.050 |
Why?
| | Mutation | 2 | 2009 | 3353 | 0.050 |
Why?
| | Rats | 5 | 2001 | 4963 | 0.050 |
Why?
| | Long-Term Potentiation | 1 | 2001 | 145 | 0.040 |
Why?
| | Risperidone | 1 | 2019 | 26 | 0.040 |
Why?
| | Language | 1 | 2022 | 258 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1034 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 429 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2023 | 547 | 0.040 |
Why?
| | Gene Expression | 1 | 2023 | 1422 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 496 | 0.040 |
Why?
| | Antidepressive Agents | 1 | 2019 | 194 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1355 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2021 | 12543 | 0.040 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 209 | 0.040 |
Why?
| | Communication | 1 | 2022 | 747 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2017 | 138 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2382 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 227 | 0.030 |
Why?
| | Animals | 7 | 2017 | 31837 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 802 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1721 | 0.030 |
Why?
| | Metformin | 1 | 2017 | 278 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2017 | 339 | 0.030 |
Why?
| | Hand Deformities | 1 | 2013 | 2 | 0.030 |
Why?
| | Megalencephaly | 1 | 2013 | 15 | 0.030 |
Why?
| | Fever | 1 | 1995 | 279 | 0.030 |
Why?
| | Brain | 2 | 1995 | 2372 | 0.030 |
Why?
| | Research | 1 | 2016 | 395 | 0.030 |
Why?
| | Taste | 1 | 1995 | 209 | 0.030 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2012 | 24 | 0.030 |
Why?
| | Microarray Analysis | 1 | 2012 | 119 | 0.020 |
Why?
| | Social Class | 1 | 2013 | 204 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 4 | 1999 | 2211 | 0.020 |
Why?
| | Introns | 1 | 2012 | 227 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2012 | 159 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2012 | 338 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2017 | 9105 | 0.020 |
Why?
| | Short Stature Homeobox Protein | 1 | 2010 | 1 | 0.020 |
Why?
| | Esophagitis | 1 | 2010 | 65 | 0.020 |
Why?
| | Gene Dosage | 1 | 2010 | 134 | 0.020 |
Why?
| | Depression | 1 | 2017 | 1133 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2009 | 87 | 0.020 |
Why?
| | Trinucleotide Repeats | 1 | 2008 | 24 | 0.020 |
Why?
| | DNA Repeat Expansion | 1 | 2008 | 5 | 0.020 |
Why?
| | Physicians | 1 | 2016 | 772 | 0.020 |
Why?
| | Ataxia | 1 | 2008 | 35 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2008 | 30 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2008 | 138 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2010 | 226 | 0.020 |
Why?
| | Fibromyalgia | 1 | 2008 | 56 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 285 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 995 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2009 | 258 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 464 | 0.020 |
Why?
| | Signal Transduction | 1 | 1999 | 4524 | 0.020 |
Why?
| | Heterozygote | 1 | 2007 | 251 | 0.020 |
Why?
| | Quality of Life | 1 | 2016 | 2359 | 0.020 |
Why?
| | Vagotomy | 2 | 1995 | 34 | 0.020 |
Why?
| | Stereotypic Movement Disorder | 1 | 2003 | 6 | 0.010 |
Why?
| | Pedigree | 1 | 2003 | 467 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1059 | 0.010 |
Why?
| | Mass Screening | 1 | 2007 | 1011 | 0.010 |
Why?
| | Phospholipase C gamma | 1 | 1999 | 26 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 1999 | 65 | 0.010 |
Why?
| | Electrophysiology | 1 | 1999 | 201 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 172 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 285 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 330 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1997 | 79 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1999 | 777 | 0.010 |
Why?
| | Saccharin | 1 | 1995 | 4 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 1856 | 0.010 |
Why?
| | Stress, Physiological | 1 | 1995 | 378 | 0.010 |
Why?
| | Aged | 1 | 2008 | 19120 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1995 | 1134 | 0.010 |
Why?
| | Cytokines | 1 | 1995 | 1843 | 0.000 |
Why?
|
|
Tartaglia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|